I can't speak for everyone, but I understood the money motivation long ago. When you're creating a product that will make some small group billions and you're okay-ing it in less than 9 months when it typically takes years to get a drug through the FDA, alarm bells go off. Then if you start "mandating" it, I'm running for the hills.
I can't speak for everyone, but I understood the money motivation long ago. When you're creating a product that will make some small group billions and you're okay-ing it in less than 9 months when it typically takes years to get a drug through the FDA, alarm bells go off. Then if you start "mandating" it, I'm running for the hills.
Well, the original claim for Operation Warp Speed was that the reason it takes years is due to ridiculously excessive FDA paperwork requirements, and the actual "safety" part could be accomplished much quicker. Now, it's true that the FDA has ridiculously excessive paperwork requirements, so possibly with other drugs the claim would have been correct. Turns out not to be in this case, because the mRNA vaccines were not fully understood to begin with.
I often tout the following: I'm under doctor's care for various chronic but so far not serious conditions (I'm aging, so the usual cholesterol, blood pressure issues, etc.) Without exception, ALL the medications I take are generics and were so prescribed. This has the obvious benefit of being relatively inexpensive. It has the less obvious benefit: a drug on generic means it's been off-patent for years, maybe decades. That also means it has a very long track record. Please spare any responses about the risks of drugs etc. I'm aware of those. The point I'm making here is that all my meds are well known as to their risks and benefits, something that is a big mystery without exception, for all the Covid-19 treatments, as well as any other drug that researchers pulled out of their ass and rammed through without any rigorous testing.
It would seem that excessive paperwork, testing and years and decades of data from the field, and might I add, not much incentive to spin that data one way or the other, since the drug is generic and the greed factor is greatly diminished, turn out to be rather desirable attributes!
I rather agree. Now if we could only figure out how to get enough safety testing without it having to cost nineteen jillion dollars, then we might get more worthwhile drugs to market.
I can't speak for everyone, but I understood the money motivation long ago. When you're creating a product that will make some small group billions and you're okay-ing it in less than 9 months when it typically takes years to get a drug through the FDA, alarm bells go off. Then if you start "mandating" it, I'm running for the hills.
Well, the original claim for Operation Warp Speed was that the reason it takes years is due to ridiculously excessive FDA paperwork requirements, and the actual "safety" part could be accomplished much quicker. Now, it's true that the FDA has ridiculously excessive paperwork requirements, so possibly with other drugs the claim would have been correct. Turns out not to be in this case, because the mRNA vaccines were not fully understood to begin with.
I often tout the following: I'm under doctor's care for various chronic but so far not serious conditions (I'm aging, so the usual cholesterol, blood pressure issues, etc.) Without exception, ALL the medications I take are generics and were so prescribed. This has the obvious benefit of being relatively inexpensive. It has the less obvious benefit: a drug on generic means it's been off-patent for years, maybe decades. That also means it has a very long track record. Please spare any responses about the risks of drugs etc. I'm aware of those. The point I'm making here is that all my meds are well known as to their risks and benefits, something that is a big mystery without exception, for all the Covid-19 treatments, as well as any other drug that researchers pulled out of their ass and rammed through without any rigorous testing.
It would seem that excessive paperwork, testing and years and decades of data from the field, and might I add, not much incentive to spin that data one way or the other, since the drug is generic and the greed factor is greatly diminished, turn out to be rather desirable attributes!
I rather agree. Now if we could only figure out how to get enough safety testing without it having to cost nineteen jillion dollars, then we might get more worthwhile drugs to market.